Jazz Pharmaceuticals, Inc. (NASDAQ:JAZZ)
CAPS Rating:
A specialty pharmaceutical company, which focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry.
RSS Headlines
Fool UK
Recs
With hot biotech sector and decent value.